MedPath

Prevention of Fetal Alcohol Spectrum Disorder (FASD) by the Use of Technology

Not Applicable
Conditions
Alcoholism
Pregnancy
Interventions
Device: specialized breathalyzer w face recognition technology
Registration Number
NCT02759874
Lead Sponsor
Institute of Health Economics, Canada
Brief Summary

The Institute of Health Economics is conducting a study to determine how a breathalyzer linked to a cloud based alcohol monitoring system changes alcohol consumption during pregnancy in women with alcohol dependency issues.

IHE posits that the ability to self-monitor blood alcohol concentration and the ability to share sobriety via email or text with loved ones and counselors may reduce alcohol consumption and thus reduce the possibility of delivering a child with FASD.

The study will provide useful evidence for tailoring future optimal maternal and child healthcare for women, with the potential of decreasing healthcare utilization by prevention of FASD. Breathalyzer device usage plus secure document sobriety should improve patient monitoring convenience and demonstrate reductions in alcohol use outside of traditional office visits and patient self-reports.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
110
Inclusion Criteria
  • Pregnant, Alcoholic, actively in treatment for alcoholism addiction
Exclusion Criteria
  • Not pregnant, not in treatment/therapy for addiction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimentalspecialized breathalyzer w face recognition technologyIntervention is pregnant women enrolled and using specialized breathalyzer device w face recognition technology linked to a cellphone
Primary Outcome Measures
NameTimeMethod
Change in FASD Birthrate Levels3 years

Binary- yes or no dx FASD within 3 years of birth

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath